| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Compound of black pepper that boosts bioavailability of curcumin piperine’s bioenhancing function, often more important than piperine’s direct anticancer activity Mechanisms of bioenhancement | Mechanism | Effect | | ----------------------------- | ---------------------------------- | | **↓ CYP3A4, CYP2C9** | Slows metabolic clearance | | **↓ UGT (glucuronidation)** | Increases parent compound exposure | | **↓ P-glycoprotein (ABCB1)** | Improves intracellular retention | | **↑ Intestinal permeability** | Better oral absorption | -Curcumin: ↑ bioavailability ~20–30× -Resveratrol, EGCG, quercetin: ↑ exposure 2–10× Primary pathways: NF-κB, STAT3, PI3K/Akt/mTOR, apoptosis, EMT Direct anticancer potency: modest Bioenhancing value: central and often dominant
|
| Source: |
| Type: transcription factor |
| CREB is a transcription factor that binds to specific DNA sequences, known as cAMP response elements (CRE), in the promoter regions of target genes. CREB is activated by phosphorylation, which allows it to bind to CRE and recruit other transcriptional coactivators. CREB regulates the expression of genes involved in various cellular processes, including: Cell growth and differentiation Apoptosis Metabolism Neurotransmission CREB is also involved in the regulation of genes involved in cancer, including: Cell cycle progression Angiogenesis Invasion and metastasis CREB is often overexpressed in cancer tissues. High levels of CREB expression are associated with poor prognosis, increased tumor aggressiveness, and resistance to therapy. CREB can promote the expression of genes involved in cell survival and proliferation. |
| 5210- | PI, | Piperine is a potent inhibitor of nuclear factor-kappaB (NF-kappaB), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells |
| - | in-vitro, | Melanoma, | B16-BL6 |
| 1016- | PI, | Piperine suppresses the Wnt/β-catenin pathway and has anti-cancer effects on colorectal cancer cells |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | SW480 | - | in-vitro, | CRC, | DLD1 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:133 Target#:798 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid